샘플 요청 목록

 카트 문의
시장보고서
상품코드
1774873

세계의 유전자 치료 임상시험 서비스 시장

Gene Therapy Clinical Trial Services
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 414 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 유전자 치료 임상시험 서비스 시장은 2030년까지 19억 달러에 이를 전망

2024년에 12억 달러로 추정되는 유전자 치료 임상시험 서비스 세계 시장은 2030년에는 19억 달러에 이르고, 분석 기간인 2024-2030년 CAGR은 8.1%를 보일 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 임상시험 디자인＆플래닝은 CAGR 10.2%를 나타내고, 분석 기간 종료시에는 5억 3,060만 달러에 이를 것으로 예측됩니다. 서플라이＆물류 서비스 분야의 성장률은 분석 기간중 CAGR 9.3%로 추정됩니다.

미국 시장은 약 3억 1,750만 달러, 중국은 CAGR 12.9%로 성장 예측

미국의 유전자 치료 임상시험 서비스 시장은 2024년에 3억 1,750만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 4억 630만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 12.9%로 추정됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 4.0%와 7.9%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 5.4%로 성장할 전망입니다.

세계의 유전자 치료 임상시험 서비스 시장 - 주요 동향과 촉진요인 정리

유전자 치료 임상시험이 급증하는 이유

유전자 치료 임상시험은 유전자 편집 기술, 바이러스 벡터 개발, 신규 유전자 치료에 대한 규제 당국의 지원 등의 발전으로 최근 그 어느 때보다 빠르게 성장하고 있습니다. 유전자 치료가 실험적 연구에서 임상 적용으로 전환됨에 따라 전문 임상시험 서비스는 이러한 획기적인 치료법의 안전성, 유효성 및 장기적 영향을 평가하는 데 중요한 역할을 하고 있습니다. 임상시험은 규제 당국의 승인 경로를 확립하고, 투여 요법을 최적화하며, 상업적 출시 전에 환자의 안전을 보장하는 데 필수적입니다.

CRISPR 기반 유전자 편집, AAV(아데노부수체 바이러스) 벡터, 체외 유전자 치료 기술의 급속한 발전으로 여러 치료 분야에 걸쳐 임상시험의 범위가 확대되고 있습니다. 희귀 유전성 질환, 유전성 대사질환, 겸상적혈구증, 베타 지중해 빈혈과 같은 혈액질환은 유전자 치료 시험의 주요 표적 중 하나입니다. 또한, CAR-T(Chimeric Antigen Receptor T-cell) 치료와 같은 유전자 변형 세포치료제가 혈액악성종양 치료에 유망한 결과를 보이면서 종양학이 주요 관심 분야로 부상하고 있습니다. 유전자 치료 임상시험에 대한 환자 등록과 투자가 증가함에 따라 전문적인 임상시험 서비스에 대한 수요는 그 어느 때보다 높아지고 있습니다.

유전자치료 임상시험의 성장을 주도하는 치료 분야는?

유전자 치료 분야는 여러 질환 영역으로 확대되고 있으며, 각 질환은 장기적인 안전성과 유효성을 보장하기 위해 엄격한 임상 평가가 필요합니다. 희귀 유전성 질환은 여전히 중요한 초점이며, 듀센형 근이영양증(DMD), 척수성 근위축증(SMA), 리소좀 저장 질환 등의 질환을 대상으로 한 임상시험이 진행되고 있습니다. 이들 임상시험의 대부분은 결손 또는 결손된 유전물질을 보완하는 기능적 유전자를 도입하기 위해 바이러스 또는 비바이러스성 전달 시스템을 활용하고 있습니다.

암 분야에서는 유전자 치료 임상시험을 통해 환자의 면역세포를 변형시켜 암과 싸우는 능력을 향상시키는 면역치료 접근법을 발전시키고 있으며, CAR-T 세포 치료는 암세포를 인식하고 파괴하도록 T세포를 유전적으로 재프로그래밍하여 백혈병, 림프종, 다발성 골수종 치료에 획기적인 진전을 가져왔습니다. 획기적인 진전을 가져왔습니다. 파킨슨병, 알츠하이머병, 헌팅턴병과 같은 신경질환도 유전자 치료 시험의 잠재적 타겟으로 부상하고 있으며, 신경 보호 유전자 변형에 초점을 맞춘 연구가 진행되고 있습니다. 치료의 폭이 넓어짐에 따라 유전자 치료 임상시험은 심혈관, 안과, 자가면역질환 치료로 확대되고 있습니다.

유전자 치료 임상시험 서비스의 최신 기술 혁신은 무엇인가?

유전자 치료 임상시험 방법론의 발전으로 임상시험 설계, 환자 모집, 규제 준수 등이 크게 개선되었습니다. 가장 중요한 혁신 중 하나는 AI 기반 분석을 사용하여 환자 선택을 간소화하고 유전자 치료의 혜택을 가장 많이 받을 가능성이 가장 높은 환자를 임상시험에 등록하는 것입니다. 또한, AI 기반 데이터 관리 플랫폼은 임상시험 모니터링을 개선하고 환자의 반응과 부작용을 실시간으로 추적할 수 있도록 돕습니다.

또한, 분산형 임상시험 모델의 개발로 환자 접근성이 향상되어 참가자들은 디지털 헬스 플랫폼을 통해 원격으로 특정 평가를 받을 수 있게 되었습니다. 유전자 및 분자 프로파일링을 통해 반응자를 식별하는 바이오마커 기반 임상시험의 등장은 임상시험의 효율성을 향상시켜 변수를 줄이고 성공률을 높임으로써 임상시험의 효율을 높이고 있습니다. 또한, FDA 및 EMA와 같은 규제 기관은 유망한 유전자 치료제에 대한 신속한 승인 경로를 도입하고 있으며, 이는 임상시험 서비스에 대한 투자 증가로 이어지고 있습니다. 이러한 발전은 유전자치료제 임상시험 프로세스를 최적화하고 연구부터 상업화까지 걸리는 시간을 단축하고 있습니다.

유전자 치료 임상시험 서비스 시장의 성장을 가속하는 요인은 무엇인가?

유전자 치료 임상시험 서비스 시장의 성장은 유전자 기반 치료법에 대한 투자 증가, 혁신적인 치료법에 대한 규제 당국의 지원, 임상시험 설계의 기술적 진보 등 여러 요인에 의해 주도되고 있습니다. 제약 및 생명공학 기업들은 유전자 치료 연구에 막대한 자원을 투입하고 있으며, 이는 전 세계적으로 임상시험의 급증으로 이어지고 있습니다. 하고 있습니다.

유전자치료제 임상시험을 전문으로 하는 임상시험수탁기관(CRO)의 확대도 시장 성장에 기여하고 있습니다. 이들 기관은 규제 당국 대응, 환자 모집, 유전자 기반 치료제에 대한 우수의약품 제조 및 품질관리기준(GMP) 준수에 대한 전문성을 제공합니다. 또한, 벡터 제조 및 유전자 도입 시스템의 발전으로 임상시험의 확장성과 효율성이 향상되고 있습니다. 유전자 치료가 질병 치료에 혁명을 가져올 것으로 예상되는 가운데, 전문 임상시험 서비스에 대한 수요는 확대되어 정밀의료와 유전자 혁신의 미래를 형성할 것으로 예측됩니다.

부문

서비스(임상시험 설계 및 계획, 공급 및 물류 서비스, 규제 서비스, 데이터 관리 및 생물 통계, 사이트 관리 및 모니터링, 기타 유전자 치료 임상시험 서비스); 치료 분야(종양학, 혈액학, 내분비/대사 장애, 근골격계 질환, 심혈관 질환, 신경학 질환, 감염성 질환, 안과, 면역학, 기타 치료 분야); 최종 사용자(제약 및 바이오테크 기업 최종 사용자, 수탁 연구 기관 최종 사용자, 학술 및 연구 기관 최종 사용자, 기타 최종 사용자)

조사 대상 기업 예

  • ACM Global Laboratories
  • BioAgilytix Labs
  • Celerion
  • Charles River Laboratories International Inc.
  • Covance Inc.(Now part of Labcorp)
  • Fortrea Holdings Inc.
  • ICON plc
  • KCR
  • Laboratory Corporation of America Holdings
  • Medpace Holdings Inc.
  • Medpace Reference Laboratories
  • Novotech
  • Parexel International Corporation
  • PPD Inc.(Thermo Fisher Scientific)
  • PRA Health Sciences
  • PSI CRO
  • SGS Life Sciences
  • Syneos Health Inc.
  • Worldwide Clinical Trials
  • WuXi AppTec

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.07.31

Global Gene Therapy Clinical Trial Services Market to Reach US$1.9 Billion by 2030

The global market for Gene Therapy Clinical Trial Services estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.9 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Clinical Trial Design & Planning, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$530.6 Million by the end of the analysis period. Growth in the Supply & Logistics Services segment is estimated at 9.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$317.5 Million While China is Forecast to Grow at 12.9% CAGR

The Gene Therapy Clinical Trial Services market in the U.S. is estimated at US$317.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$406.3 Million by the year 2030 trailing a CAGR of 12.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Gene Therapy Clinical Trial Services Market - Key Trends & Drivers Summarized

Why Are Gene Therapy Clinical Trials Expanding Rapidly?

Gene therapy clinical trials have witnessed unprecedented growth in recent years, driven by advancements in gene-editing technologies, viral vector development, and regulatory support for novel genetic treatments. As gene therapy moves from experimental research to clinical application, specialized clinical trial services are playing a crucial role in evaluating the safety, efficacy, and long-term impact of these groundbreaking therapies. Clinical trials are essential for establishing regulatory approval pathways, optimizing dosing regimens, and ensuring patient safety before commercial deployment.

The rapid development of CRISPR-based gene editing, AAV (Adeno-Associated Virus) vectors, and ex vivo gene therapy techniques has expanded the scope of clinical trials across multiple therapeutic areas. Rare genetic disorders, inherited metabolic diseases, and hematological conditions such as sickle cell disease and beta-thalassemia are among the primary targets of gene therapy trials. Additionally, oncology has emerged as a major focus area, with gene-modified cell therapies such as CAR-T (Chimeric Antigen Receptor T-cell) therapy demonstrating promising results in treating hematologic malignancies. With increasing patient enrollment and investment in gene therapy trials, the demand for specialized clinical trial services is at an all-time high.

Which Therapeutic Areas Are Driving the Growth of Gene Therapy Clinical Trials?

The field of gene therapy is expanding into multiple disease areas, each requiring rigorous clinical evaluation to ensure long-term safety and effectiveness. Rare genetic disorders remain a significant focus, with clinical trials targeting conditions such as Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), and lysosomal storage diseases. Many of these trials leverage viral and non-viral delivery systems to introduce functional genes that compensate for defective or missing genetic material.

In oncology, gene therapy clinical trials are advancing immunotherapy approaches that modify a patient’s immune cells to enhance cancer-fighting capabilities. CAR-T cell therapy, which involves genetically reprogramming T cells to recognize and destroy cancer cells, has led to breakthroughs in leukemia, lymphoma, and multiple myeloma treatment. Neurological disorders such as Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease are also emerging as potential targets for gene therapy trials, with research focusing on neuroprotective gene modifications. As the therapeutic landscape broadens, gene therapy clinical trials are expanding into cardiovascular, ophthalmic, and autoimmune disease treatments.

What Are the Latest Innovations in Gene Therapy Clinical Trial Services?

Advancements in gene therapy trial methodologies have significantly improved trial design, patient recruitment, and regulatory compliance. One of the most important innovations is the use of AI-driven analytics to streamline patient selection, ensuring that clinical trials enroll individuals with the highest likelihood of benefiting from gene therapy. AI-powered data management platforms are also improving trial monitoring, enabling real-time tracking of patient responses and adverse events.

Additionally, the development of decentralized clinical trial models has increased patient accessibility, allowing participants to undergo certain assessments remotely through digital health platforms. The rise of biomarker-driven trials, which use genetic and molecular profiling to identify responders, has enhanced trial efficiency by reducing variability and increasing success rates. Furthermore, regulatory agencies such as the FDA and EMA have introduced accelerated approval pathways for promising gene therapies, leading to increased investment in clinical trial services. These advancements are optimizing the gene therapy trial process, accelerating the timeline from research to commercialization.

What Factors Are Fueling the Growth of the Gene Therapy Clinical Trial Services Market?

The growth in the gene therapy clinical trial services market is driven by several factors, including rising investment in gene-based treatments, regulatory support for innovative therapies, and technological advancements in clinical trial design. Pharmaceutical and biotech companies are dedicating substantial resources to gene therapy research, leading to a surge in trial activity worldwide. The success of FDA-approved gene therapies, such as Luxturna and Zolgensma, has further validated the potential of gene therapy, encouraging increased clinical trial participation.

The expansion of contract research organizations (CROs) specializing in gene therapy trials has also contributed to market growth. These organizations provide expertise in regulatory navigation, patient recruitment, and compliance with Good Manufacturing Practices (GMP) for gene-based treatments. Additionally, advancements in vector manufacturing and gene delivery systems have improved trial scalability and efficiency. With gene therapy expected to revolutionize disease treatment, the demand for specialized clinical trial services is projected to grow, shaping the future of precision medicine and genetic innovation.

SCOPE OF STUDY:

The report analyzes the Gene Therapy Clinical Trial Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Services (Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring, Other Gene Therapy Clinical Trial Services); Therapeutic Area (Oncology, Hematology, Endocrine / Metabolic Disorders, Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas); End-User (Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • ACM Global Laboratories
  • BioAgilytix Labs
  • Celerion
  • Charles River Laboratories International Inc.
  • Covance Inc. (Now part of Labcorp)
  • Fortrea Holdings Inc.
  • ICON plc
  • KCR
  • Laboratory Corporation of America Holdings
  • Medpace Holdings Inc.
  • Medpace Reference Laboratories
  • Novotech
  • Parexel International Corporation
  • PPD Inc. (Thermo Fisher Scientific)
  • PRA Health Sciences
  • PSI CRO
  • SGS Life Sciences
  • Syneos Health Inc.
  • Worldwide Clinical Trials
  • WuXi AppTec

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Gene Therapy Clinical Trial Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Cell and Gene Therapy Development Pipelines Drives Outsourcing of Gene Therapy Clinical Trial Services
    • Rising Complexity of Vector Manufacturing and Dosing Protocols Spurs Demand for Specialized Trial Management Services
    • Expansion of Rare Disease and Orphan Drug Research Increases Need for Niche Patient Recruitment Strategies
    • OEM Expertise in Regulatory Navigation and Trial Design Accelerates First-in-Human Gene Therapy Studies
    • Growth in Pediatric Gene Therapy Trials Creates Demand for Custom Trial Sites and Safety Monitoring Capabilities
    • Increasing Pressure to Shorten Development Timelines Fuels Demand for End-to-End Clinical Trial Services for Gene Therapies
    • Advancement in AAV, Lentiviral, and Non-Viral Delivery Vectors Requires Specialized CMC and GMP Oversight
    • High Capital Requirements for Gene Therapy Trials Encourage Outsourcing to Full-Service CROs and Niche Providers
    • Focus on Long-Term Follow-Up and Post-Treatment Monitoring Expands Scope of Clinical Data Management Services
    • Demand for Decentralized and Remote Trial Models Enhances Access to Rare Disease Populations
    • Increased Regulatory Scrutiny for Cell and Gene Therapies Elevates Importance of Specialized Clinical Compliance Services
    • OEM Partnerships with Biotech Innovators Create Customized Trial Frameworks for Novel Therapeutic Modalities
    • Growing Need for Advanced Biomarker and Genomic Endpoint Analysis Drives Integration of Omics in Trial Design
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Gene Therapy Clinical Trial Services Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Gene Therapy Clinical Trial Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Gene Therapy Clinical Trial Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Clinical Trial Design & Planning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Clinical Trial Design & Planning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Clinical Trial Design & Planning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Supply & Logistics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Supply & Logistics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Supply & Logistics Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Regulatory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Regulatory Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Regulatory Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Data Management & Biostatistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Data Management & Biostatistics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Data Management & Biostatistics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Site Management & Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Site Management & Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Site Management & Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Gene Therapy Clinical Trial Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Gene Therapy Clinical Trial Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Gene Therapy Clinical Trial Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Musculoskeletal Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Musculoskeletal Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Musculoskeletal Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Neurology Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Neurology Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Neurology Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Endocrine / Metabolic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Endocrine / Metabolic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: World 15-Year Perspective for Endocrine / Metabolic Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Pharma & Biotech Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: World 15-Year Perspective for Pharma & Biotech Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Contract Research Organizations End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Contract Research Organizations End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: World 15-Year Perspective for Contract Research Organizations End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 59: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: World Historic Review for Academic & Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: World 15-Year Perspective for Academic & Research Institutes End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 62: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 63: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gene Therapy Clinical Trial Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 65: USA Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: USA 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 68: USA Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: USA 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 71: USA Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: USA Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: USA 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Canada 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Canada 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Canada 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • JAPAN
    • Gene Therapy Clinical Trial Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Japan 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Japan 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Japan 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • CHINA
    • Gene Therapy Clinical Trial Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 92: China Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: China 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: China 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 98: China Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: China 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • EUROPE
    • Gene Therapy Clinical Trial Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Gene Therapy Clinical Trial Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for Gene Therapy Clinical Trial Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Europe 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Europe 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • FRANCE
    • Gene Therapy Clinical Trial Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 113: France Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 116: France Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: France Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: France 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 119: France Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: France 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • GERMANY
    • Gene Therapy Clinical Trial Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Germany 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 128: Germany Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Germany Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Germany 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Italy 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Italy 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Gene Therapy Clinical Trial Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 140: UK Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: UK 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Russia 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Europe 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Gene Therapy Clinical Trial Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for Gene Therapy Clinical Trial Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Asia-Pacific 15-Year Perspective for Gene Therapy Clinical Trial Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Asia-Pacific 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Gene Therapy Clinical Trial Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 188: Australia Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Australia Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Australia 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 191: Australia Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Australia Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Australia 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 194: Australia Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Australia Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Australia 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • INDIA
    • Gene Therapy Clinical Trial Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 197: India Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: India Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: India 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 200: India Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: India Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: India 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 203: India Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: India Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: India 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 206: South Korea Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: South Korea Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: South Korea 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 209: South Korea Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: South Korea Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: South Korea 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 212: South Korea Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: South Korea Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: South Korea 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 215: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Asia-Pacific Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Rest of Asia-Pacific 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 218: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Asia-Pacific Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Rest of Asia-Pacific 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 221: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Rest of Asia-Pacific Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Rest of Asia-Pacific 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Gene Therapy Clinical Trial Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 224: Latin America Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 225: Latin America Historic Review for Gene Therapy Clinical Trial Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Latin America 15-Year Perspective for Gene Therapy Clinical Trial Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 227: Latin America Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Latin America Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Latin America 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 230: Latin America Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Latin America Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Latin America 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 233: Latin America Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Latin America Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Latin America 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 236: Argentina Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Argentina Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Argentina 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 239: Argentina Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Argentina Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Argentina 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 242: Argentina Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Argentina Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Argentina 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 245: Brazil Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Brazil Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Brazil 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 248: Brazil Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Brazil Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Brazil 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 251: Brazil Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Brazil Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Brazil 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 254: Mexico Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Mexico Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Mexico 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 257: Mexico Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Mexico Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Mexico 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 260: Mexico Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Mexico Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Mexico 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 263: Rest of Latin America Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Rest of Latin America Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Rest of Latin America 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 266: Rest of Latin America Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Rest of Latin America Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Rest of Latin America 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 269: Rest of Latin America Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Rest of Latin America Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Rest of Latin America 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Gene Therapy Clinical Trial Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 272: Middle East Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 273: Middle East Historic Review for Gene Therapy Clinical Trial Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Middle East 15-Year Perspective for Gene Therapy Clinical Trial Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 275: Middle East Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Middle East Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Middle East 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 278: Middle East Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Middle East Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Middle East 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 281: Middle East Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Middle East Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Middle East 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 284: Iran Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Iran Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Iran 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 287: Iran Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Iran Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Iran 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 290: Iran Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Iran Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Iran 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 293: Israel Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Israel Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Israel 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 296: Israel Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Israel Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Israel 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 299: Israel Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Israel Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Israel 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 302: Saudi Arabia Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Saudi Arabia Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Saudi Arabia 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 305: Saudi Arabia Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Saudi Arabia Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Saudi Arabia 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 308: Saudi Arabia Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Saudi Arabia Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Saudi Arabia 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 311: UAE Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: UAE Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: UAE 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 314: UAE Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: UAE Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: UAE 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 317: UAE Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: UAE Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: UAE 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 320: Rest of Middle East Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Middle East Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Rest of Middle East 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 323: Rest of Middle East Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Rest of Middle East Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Rest of Middle East 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 326: Rest of Middle East Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Rest of Middle East Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Rest of Middle East 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030
  • AFRICA
    • Gene Therapy Clinical Trial Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 329: Africa Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Africa Historic Review for Gene Therapy Clinical Trial Services by Services - Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Africa 15-Year Perspective for Gene Therapy Clinical Trial Services by Services - Percentage Breakdown of Value Sales for Clinical Trial Design & Planning, Supply & Logistics Services, Regulatory Services, Data Management & Biostatistics, Site Management & Monitoring and Other Gene Therapy Clinical Trial Services for the Years 2015, 2025 & 2030
    • TABLE 332: Africa Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Africa Historic Review for Gene Therapy Clinical Trial Services by Therapeutic Area - Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Africa 15-Year Perspective for Gene Therapy Clinical Trial Services by Therapeutic Area - Percentage Breakdown of Value Sales for Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Therapeutic Areas, Oncology, Hematology and Endocrine / Metabolic Disorders for the Years 2015, 2025 & 2030
    • TABLE 335: Africa Recent Past, Current & Future Analysis for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Africa Historic Review for Gene Therapy Clinical Trial Services by End-user - Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Africa 15-Year Perspective for Gene Therapy Clinical Trial Services by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Contract Research Organizations End-User, Academic & Research Institutes End-User and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제